ADALTA LIMITED (1AD)

---

AI Coverage Rating: Moderate

ASX AI Signals has generated 2 signal(s) for 1AD during the last 90 days, indicating Moderate trading activity

Latest 1AD Signals
02/07/2026	BUY
21/05/2026	SELL
1AD Share Price
Current Price	$0.004
52 Week High	$0.007
52 Week Low:	$0.002
Trading at (% of 52 Week High)	57.14%

Business Overview

Adalta Limited (ASX: 1AD) is a biotechnology company focused on developing and commercializing novel protein-based therapeutics. The company specializes in engineering AdNectin® proteins to treat fibrosis, cancer, and other serious diseases.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal on ADALTA LIMITED at a very low price point suggests potential upside, but the overall confidence is limited due to the stock's low price and likely high volatility. Additional fundamental and market data are needed to increase conviction.

Latest  ADALTA LIMITED(1AD)   News